Acute Lung Injury Models

Wild Mouse 750
Wild Mouse 750
Human Xenograft Models
Cell Derived Xenograft Models
Autoimmune Disease Models
Autoimmune Nephropathy modelsAcute Lung Injury ModelsIdiopathic Pulmonary Fibrosis ModelsSjögren’ s Syndrome ModelsSystemic Lupus Erythematosus (SLE) ModelsMultiple Sclerosis ModelsRheumatoid Arthritis ModelsPsoriasis ModelsInflammatory Bowel Disease ModelsAtopic Dermatitis Models Asthma Models
Metabolic Disease Mouse Models
Obesity ModelsDiabetes ModelsMASH ModelsHyperlipidemia ModelsOsteoporosis ModelsHyperuricemia Models
Humanized Immune System Models
huPBMC-NCGhuHSC-NCG-XhuHSC-NCG-hIL15huHSC-NCG
Organs or Tissue Humanized Mouse Models
Wild Mouse 765
Wild Mouse 765
Rare Disease Mouse Models
Progressive Muscular Dystrophy ModelsHemophilia A Models
Neurodegenerative Disease Mouse Models
Alzheimer’s Disease (AD) ModelsParkinson’s Disease (PD) ModelsHuntington's Disease (HD) ModelsAmyotrophic Lateral Sclerosis (ALS) ModelsTransthyretin Amyloidosis (ATTR) Models
Immuno-Oncology Mouse Models
Human Xenograft ModelsHumanized Immune Checkpoint ModelsHumanized Immune System ModelsSpontaneous Tumor Models

Acute lung injury (ALI) is a form of acute respiratory failure, defined by hypoxemia and the presence of bilateral infiltrates on chest radiograph, and often referred to by its most severe subset known as acute respiratory distress syndrome (ARDS).


1. LPS-induced acute lung injury 


图片20.png


Validation data


图片21.png

Both low and high doses of LPS can effectively induce acute lung injury and inflammatory cytokine secretion.


Drug efficacy evaluation


图片22.png

Dexamethasone can effectively reduce the secretion of inflammatory factors caused by acute lung injury.


图片23.png

HE staining results of pathological sections showed that dexamethasone could effectively relieve lung inflammation (Day4).